![Paris Panayiotopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paris Panayiotopoulos
Président chez
FerGene, Inc.
Profil
Paris Panayiotopoulos was the founder of Anthos Therapeutics, Inc., founded in 2019, serving as Director from 2019 to 2025.
Mr. Panayiotopoulos was the founder of AvenCell Therapeutics, Inc., founded in 2021, serving as Director.
Current jobs include Co-Chairman at FerGene, Inc., Director at European Pharmaceutical Market Research Association, Senior Managing Director at Blackstone Life Sciences Advisors LLC since 2018, and Member at Chamber of Commerce of The United States of America.
Former jobs include President, Chief Executive Officer & Director at ARIAD Pharmaceuticals, Inc. from 2016 to 2017; Chairman at Genevant Sciences Corp.
from 2018 to 2020; Director at The Medicines Co. from 2017 to 2020; Director at Biotechnology Innovation Organization; Independent Director at Corbus Pharmaceuticals Holdings, Inc. from 2017 to 2020; Chief of Staff at Merck KGaA from 2012 to 2013; Principal at Eli Lilly & Co. Ltd. from 1999 to 2004; President at EMD Serono, Inc. from 2014 to 2016; Partner at Clarus Ventures LLC in 2018; and President at Merck Serono Co., Ltd. from 2013 to 2014.
Education includes an undergraduate degree from University College London in 1996 and a graduate degree from Cranfield School of Management in 1997.
Postes actifs de Paris Panayiotopoulos
| Sociétés | Poste | Début |
|---|---|---|
European Pharmaceutical Market Research Association | Directeur/Membre du Conseil | - |
Chamber of Commerce of The United States of America
 Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Corporate Officer/Principal | - |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Président | - |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Private Equity Investor | 01/12/2018 |
Anciens postes connus de Paris Panayiotopoulos
| Sociétés | Poste | Fin |
|---|---|---|
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Fondateur | 01/04/2025 |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Président | 31/07/2020 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 06/03/2020 |
| THE MEDICINES COMPANY | Directeur/Membre du Conseil | 31/01/2020 |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Private Equity Investor | 30/11/2018 |
Formation de Paris Panayiotopoulos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Chamber of Commerce of The United States of America
Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Merck Serono Co., Ltd. | |
European Pharmaceutical Market Research Association | |
Cranfield School of Management
 Cranfield School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Health Technology |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Health Technology |
